WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices

Completed

Conditions: Supportive Care

First Posted Date: 2018-11-19

Last Posted Date: 2022-03-02

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 910

Registration Number: NCT03746314

Locations: 🇺🇸
Mercy Hospital, Coon Rapids, Minnesota, United States
🇺🇸
Southwest Oncology PC, Durango, Colorado, United States
🇺🇸
Longmont United Hospital, Longmont, Colorado, United States

and more 268 locations

Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung Cancer

Completed

Conditions: Non Small Cell Lung Cancer

First Posted Date: 2018-11-19

Last Posted Date: 2018-11-21

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 40

Registration Number: NCT03746262

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Phase 2

Withdrawn

Conditions: Opioid Use

Interventions: Drug: Suboxone® SL
Drug: Sublocade®

First Posted Date: 2018-11-16

Last Posted Date: 2022-06-06

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03744663

TS Overexpression in SCLC: Mechanism and Therapeutic Targeting

Completed

Conditions: Small Cell Lung Cancer

First Posted Date: 2018-11-15

Last Posted Date: 2020-02-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 12

Registration Number: NCT03741829

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy

Completed

Conditions: Lung Neoplasm

First Posted Date: 2018-11-15

Last Posted Date: 2020-07-24

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03741868

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
🇺🇸
Laurie E Steffen, Winston-Salem, North Carolina, United States

A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease

Phase 3

Completed

Conditions: End Stage Renal Failure on Dialysis

Interventions: Other: Hemodialysis
Drug: Patiromer Oral Product

First Posted Date: 2018-11-14

Last Posted Date: 2023-06-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 51

Registration Number: NCT03740048

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients

Terminated

Conditions: Sedentary Lifestyle

Interventions: Device: eHealth for Sedentary Behavior

First Posted Date: 2018-11-14

Last Posted Date: 2022-03-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 4

Registration Number: NCT03740035

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Angiotensin II in General Anesthesia

Phase 1

Recruiting

Conditions: Hypertension

Interventions: Drug: Angiotensin II

First Posted Date: 2018-11-07

Last Posted Date: 2024-04-29

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03733145

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Dietary Cholesterol and Adipose Tissue Inflammation

Not Applicable

Withdrawn

Conditions: Cholesterol

Interventions: Dietary Supplement: Added Cholesterol
Other: No Added Cholesterol

First Posted Date: 2018-11-02

Last Posted Date: 2019-11-04

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03729141

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

The Use Of Liposomal Bupivacaine For Pain Control

Phase 4

Completed

Conditions: Pain, Breast

Interventions: Drug: Liposomal Bupivacaine
Drug: Bupivacaine

First Posted Date: 2018-10-29

Last Posted Date: 2022-10-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 3

Registration Number: NCT03722927

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy